SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 273 filers reported holding SAGE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $51,356,000 | -22.8% | 366,068 | +0.7% | 2.62% | -16.0% |
| Q2 2019 | $66,541,000 | +19.4% | 363,432 | +3.7% | 3.12% | +11.4% |
| Q1 2019 | $55,726,000 | +311.4% | 350,368 | +147.7% | 2.80% | +251.4% |
| Q4 2018 | $13,547,000 | -31.3% | 141,426 | +1.3% | 0.80% | -8.5% |
| Q3 2018 | $19,725,000 | +4.7% | 139,646 | +16.0% | 0.87% | -9.9% |
| Q2 2018 | $18,847,000 | +26.4% | 120,408 | +30.1% | 0.97% | +15.5% |
| Q1 2018 | $14,912,000 | – | 92,583 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |